Related Experiment Video
Updated: Mar 9, 2026
Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
Published on: July 12, 2018
Anticytotoxin Effects of Amentoflavone to Pneumolysin
Xiaoran Zhao1, Bowen Liu, Shui Liu
1Key Laboratory of Zoonosis, Ministry of Education, College of Veterinary Medicine, Jilin University.
Abstract:
Pneumolysin (PLY) is a devastating bacterial protein toxin of Streptococcus pneumoniae that punctures the cytomembrane, leading to pathological reactions, such as cell disruption and inflammation. Drugs capable of closely impacting the toxin are considered advantageous in the treatment of bacterial infections. Amentoflavone (AMF) is a chemical substance extracted from traditional Chinese herbs. Previous studies have demonstrated that AMF has multiple pharmacological effects and mentioned without attenuating pneumolysin-mediated cytotoxicity. This work focuses on the influence of AMF on inhibitory hemolytic mechanisms. AMF interacts with the toxin at Ser254, Glu277, Arg359, and effectively weakens the oligomerization of wild-type PLY and provides considerable protection against pneumolysin-mediated human alveolar epithelial (A549) cell damage. The results of our study demonstrate that AMF could be a candidate against pneumolysin-related injury.
Insights
Amentoflavone (AMF) weakens pneumolysin (PLY) toxin activity by inhibiting its oligomerization. This natural compound protects against PLY-induced cell damage, offering a potential therapeutic strategy for bacterial infections.
Area of Science:
- Microbiology
- Pharmacology
- Biochemistry
Background:
- Pneumolysin (PLY) from Streptococcus pneumoniae causes cell damage and inflammation.
- Targeting bacterial toxins is a key strategy for treating infections.
- Amentoflavone (AMF), a herbal extract, has shown various pharmacological effects.
Purpose of the Study:
- To investigate the inhibitory effects of Amentoflavone (AMF) on pneumolysin (PLY).
- To determine AMF's mechanism of action against PLY-mediated cytotoxicity.
- To evaluate AMF as a potential therapeutic agent against PLY-induced cellular injury.
Main Methods:
- Biochemical assays to assess AMF's interaction with PLY.
- Analysis of PLY oligomerization in the presence of AMF.
- Cell-based assays using human alveolar epithelial (A549) cells to measure protection against PLY.
Main Results:
- Amentoflavone (AMF) directly interacts with pneumolysin (PLY) at specific amino acid residues (Ser254, Glu277, Arg359).
- AMF significantly weakens the oligomerization of wild-type PLY.
- AMF provides substantial protection to A549 cells against PLY-induced damage.
Conclusions:
- Amentoflavone (AMF) effectively inhibits pneumolysin (PLY) by disrupting its oligomerization process.
- AMF demonstrates protective effects against pneumolysin-mediated cytotoxicity in human alveolar epithelial cells.
- Amentoflavone (AMF) is a promising candidate for developing novel therapeutics against pneumolysin-related injuries.
More Related Videos
12:04Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
Published on: May 9, 2018
08:34Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
Published on: February 22, 2017
